METTLER TOLEDO INTERNATIONAL INC/ (MTD) Company Report

The industrial segment delivered 10% organic growth in Q3 FY2025, with double-digit gains in the Americas and Europe and the first industrial growth in China in two years.
For FY2026, management expects low- to mid-single-digit growth in both the core industrial and product inspection businesses, with organic growth closer to low single digits, excluding acquisition contributions.
The lab division saw strong bioprocess and process analytics performance—driven by bioproduction and semiconductor ultra-pure water demand—while liquid-handling pipettes are expected to remain below corporate average growth.
Service revenue runs at about $1 billion versus a $3 billion serviceable installed base, and the company aims for above-average service growth through targeted penetration initiatives.
Q4 FY2025 margins face headwinds from 200 bps of tariffs and 70 bps of currency impacts, though tariff mitigation and organizational agility have offset much of the pressure.

2 days ago

Transcript

Mettler-Toledo outlines FY2026 guidance and strategic priorities at Citi Healthcare Conference

MTD

Guidance Update

M&A

FY2026 guidance targets low- to mid-single-digit revenue growth, including ~2.5% pricing, ~1% contribution from recent bolt-on acquisitions and ~1% organic volume growth amid cautiously positioned market assumptions
Bolt-on acquisitions completed in FY2025 are expected to contribute ~100 bps per quarter in FY2026, primarily on the industrial side, enhancing direct distribution, service offerings and expanding the life-science equipment portfolio
Tariff and currency impacts will pressure Q4 2025 gross margins by ~200 bps and operating margins by ~70 bps; mitigation actions limit incremental Swiss tariff effects to <1% EPS upside in FY2026
Market trends: Chinese industrial returned to growth driven by pharmaceuticals, food manufacturing and specialty chemicals; lab segment shows strength in bioprocess analytics and process sensors, with softer liquid handling amid academic funding pressures

2 days ago

Transcript

Mettler-Toledo outlines FY2026 outlook at Evercore HealthCONx

MTD

Guidance Update

Mettler-Toledo highlighted its innovation pedigree—80–120 years across its brands—and holds the global #1 position in 75–80% of its ~25 niche markets with an average ~25% market share, driven by its Spinnaker program and 3,000 direct sales staff.
The company’s revenue split is 55% laboratory, 40% industrial (25% core industrial; 15% product inspection), and 5% food retail, with key offerings spanning balances, analytical instruments, liquid handling, AutoChem synthesis, and bioprocessing analytics.
Average selling price is under $10,000, sold directly to end users, enabling consistent 1–2% pricing increases and rigorous price-leakage management.
For FY2026, Mettler-Toledo guides to low–mid single-digit organic growth, reflecting caution on macro uncertainty, softer European markets, and tougher comparables in product inspection.
Services are expected to grow mid–high single digits, leveraging a $3 billion serviceable install base against a $1 billion installed base, supported by targeted investments in service capabilities.

3 days ago

Transcript

Mettler-Toledo presents strategic update and FY26 guidance

MTD

Guidance Update

Mettler-Toledo emphasizes its innovation-led competitive advantage across ~25 niche product categories, leveraging the Spinnaker operational-excellence program and disciplined pricing (average price <$10k) to drive share gains and margin capture.
The business mix is 55% laboratory products, 40% industrial (25% core, 15% product inspection) and 5% food retail; end-market exposure is 40% pharma/bio-pharma, 20% food manufacturing and 10–15% specialty chemical.
Digitalization efforts include completion of the Blue Ocean ERP/CRM harmonization, deployment of automation bots and generative-AI tools (e.g., ChatMT), plus embedded AI in customer products for predictive analytics (AutoChem).
In 3Q 2025, core industrial grew 10% organically and product inspection high-single digits; 4Q guide steps to low-single digits (core) and high-single digits (PID), with FY 2026 growth expected in the low-to-mid single digits and services in mid-to-high single digits.
China returned to low-single-digit growth in both lab and industrial segments in 3Q after two years, supported by a China-for-China strategy and rising GLP-1 biopharma activity.

3 days ago

Transcript

Mettler-Toledo reports Q3 2025 results

MTD

Earnings

Guidance Update

Q3 sales were $1.03 billion, up 6% in local currency (8% reported), led by 10% growth in the Americas, 6% in Europe, and 1% in Asia.
Gross margin declined 80 bps to 59.2%, adjusted operating profit rose 5% to $309.9 million, with operating margin at 30.1% (down 100 bps); adjusted EPS was $11.15, up 9%.
Adjusted free cash flow for the first nine months was $689.5 million, a 6% increase per share; DSO was 34 days and ITO 4.2×.
Q4 guidance calls for ~3% local-currency sales growth and adjusted EPS of $12.68–$12.88 (2–4% growth); full-year 2025 EPS forecast is $42.05–$42.25 (2–3% growth).

Nov 7, 2025, 1:30 PM

Transcript

Mettler-Toledo reports Q3 2025 results

MTD

Earnings

Guidance Update

M&A

$1.03 billion in Q3 sales, up 6% in local currency (8% in USD); excluding recent acquisitions, sales increased 5% versus prior year.
Segment growth: laboratory sales +4%, industrial +9% (10% core ex-acquisitions), product inspection +7%, service +8% (1% acquisition benefit).
Gross margin of 59.2% (down 80 bps); adjusted operating margin 30.1% (down 100 bps; 30 bps currency-neutral); tariffs reduced operating margin by 140 bps.
Adjusted EPS of $11.15, a 9% increase year-over-year; reported EPS $10.57 vs. $9.96 in Q3 2024.
2026 outlook: forecasting ~4% sales growth, expecting to fully offset incremental tariff costs; recent small acquisitions to add <1% to 2026 sales.

Nov 7, 2025, 1:30 PM

Transcript

Mettler-Toledo reports Q3 2025 earnings

MTD

Earnings

Guidance Update

Share Buyback

Q3 sales of $1.03 billion, up 6% in local currency (8% reported), driven by industrial (+9%) and service (+8%) growth.
Gross margin of 59.2% (-80 bps), adjusted operating profit of $309.9 million (30.1% margin, ‑100 bps), and adjusted EPS of $11.15 (+9% YOY).
2026 guidance for adjusted EPS of $45.35–46.00 (+8–9%), free cash flow of $900 million, and $825–875 million in share repurchases.
Board approved an additional $2.75 billion for the share buyback program; $800 million planned repurchases in 2025.

Nov 7, 2025, 1:30 PM

Transcript

Mettler-Toledo announces Q3 2025 results

MTD

Earnings

Mettler-Toledo reports net sales of $1,029.7 M, up 8% YoY; gross profit margin fell to 59.2% (–80 bp).
Q3 local currency sales increased 6%, with an adjusted operating margin of 30.1% (–100 bp) and adjusted EPS of $11.15 (+9%).
Regional mix: Europe +6%, Asia/ROW +4%, Americas –1% LC.
Segment trends: Laboratory +5%, Industrial flat, Food Retail –20% LC.

Nov 7, 2025, 1:30 PM

Presentation

Mettler-Toledo reports Q3 2025 results

MTD

Earnings

Guidance Update

Share Buyback

Q3 2025 net sales were $1,029.7 million, an 8% increase (6% in local currency); GAAP diluted EPS was $10.57 vs $9.96 prior year, and adjusted EPS was $11.15, up 9%.
Regional sales grew 10% in the Americas, 13% in Europe, and 1% in Asia/Rest of World.
For the nine months ended September 30, 2025, net sales were $2,896.7 million, up 2%; GAAP diluted EPS was $28.12 vs $28.55 prior year, and adjusted EPS was $29.41, up 2%.
The board authorized an additional $2.75 billion to the share repurchase program, with $1.1 billion remaining as of September 30, 2025.
Management forecasts Q4 2025 local currency sales up ~3% and adjusted EPS of $12.68–$12.88; full-year 2025 adjusted EPS guidance is $42.05–$42.25.

Nov 6, 2025, 9:42 PM

8-K

Mettler-Toledo reports third quarter 2025 results

MTD

Earnings

Third quarter net sales rose 8% to $1,029.7 million (up 6% in local currency)
GAAP EPS was $10.57, up from $9.96; non-GAAP Adjusted EPS was $11.15, a 9% increase
Adjusted operating profit for the quarter was $309.9 million, up from $296.6 million
Regional sales growth: Americas +10%, Europe +13%, Asia/Rest of World +1%
Year-to-date sales rose 2% to $2.897 billion, with Adjusted EPS up 2% to $29.41

Nov 6, 2025, 9:30 PM

Press Release

Earnings Transcripts

Quarterly earnings call transcripts for METTLER TOLEDO INTERNATIONAL INC/.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did Patrick Kaltenbach say about margins?What are METTLER TOLEDO INTERNATIONAL INC/'s strategic priorities?How is METTLER TOLEDO INTERNATIONAL INC/ positioned vs competitors?How did METTLER TOLEDO INTERNATIONAL INC/ do last quarter?

Let Fintool AI Agent track METTLER TOLEDO INTERNATIONAL INC/'s earnings for you

Get instant analysis when filings drop